Skip to content

News Category: Health & Medical

Encore Medical Education announces publication of the Official Best of SABCS(R) News Highlights summarizing key trial results from the 2022 SABCS(R)

By asianet

– Best of SABCS(R) News Highlights coverage will provide daily expert video summaries along with original presentation slides of the most significant breast cancer trials for oncologists worldwide. Encore Medical Education [http://www.encoremeded.com/], a US-based medical education company will launch the 2022 edition of the Best of SABCS(R) News [https://bestofsabcsnews.com/] Highlights program from the 2022 San … Continued

New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio

By asianet

ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with Cosmo Bio. This is a non-exclusive license agreement granting Japan’s Cosmo Bio access to the ERS CRISPR/Cas9 patent portfolio. ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner for gene-editing, provides access to the foundational CRISPR/Cas9 intellectual property. Over 100 patents … Continued

LUCIDITY phase 3 topline data presented at CTAD for HMTM – the only oral anti-Tau therapy in late-stage development

By asianet

– Tau aggregation inhibitor, HMTM, is an oral drug with a strong safety profile, having no risk of amyloid related imaging abnormalities – Topline results for the Phase 3 study, LUCIDITY, were shared at the Clinical Trials in Alzheimer’s Disease (CTAD) conference on Wednesday, 30th November 2022, in San Francisco – For people with early … Continued

Menarini Group Presents Updated Results from Pivotal Phase 3 EMERALD Trial at the 2022 San Antonio Breast Cancer Symposium (SABCS) that Demonstrate Elacestrant’s PFS Increases with Duration of Prior CDK4/6i in ER+, HER2- in Metastatic Setting

By asianet

• Elacestrant demonstrated longer progression-free survival (PFS) vs SOC endocrine therapy with medians up to 8.6 months, positively associated with the duration of prior treatment with CDK4/6 inhibitors • Elacestrant side effects were manageable and consistent with previously reported results • Results demonstrate that elacestrant may have the potential to become a new standard of … Continued

Global alliance of heart patient organizations unveils new Global Cholesterol Action Plan to prioritize unhealthy cholesterol as a main public health issue

By asianet

The Global Heart Hub has today launched its Global Cholesterol Action Plan[https://invisiblenation.globalhearthub.org/] to reduce the impact of unhealthy cholesterol levels . Presented at their annual UNITE Summit , the Action Plan follows and builds upon the World Heart Federation’s Cholesterol Roadmap released in October. Atherosclerotic cardiovascular disease (ASCVD) accounts for 85% of all cardiovascular-related deaths … Continued

TargEDys and SymbioPharm enter an exclusive partnership to launch SymbioLife(R) Satylia(R) in Germany

By asianet

TargEDys and SymbioPharm signed an exclusive marketing and distribution agreement for the launch of SymbioLife(R) Satylia(R) in Germany. The novel dietary supplement based on the next-generation probiotic Hafnia alvei HA4597 will be available from January 2023. SymbioLife(R) Satylia(R) is a precision probiotic with a characterized mechanism of action at molecular level: it increases satiety thanks … Continued

Probiotic strain SNZ 1969(R) helps manage IBS-D & IBS-C symptoms effectively, latest clinical study shows

By asianet

Latest study shows Sanzyme Biologics’s Bacillus coagulans SNZ 1969(R)(Weizmannia coagulans SNZ 1969), a natural spore forming probiotic strain over five decades of use and more than 30 human studies across age groups found to be effective in managing IBS symptoms. This study is unique as it covers both the IBS-Diarrhea and IBS-Constipation groups with larger … Continued

COLOTECT – Non-invasive Colorectal Cancer Screening Test has been launched in Southeast Asia

By asianet

COLOTECT is a non-invasive colorectal cancer (CRC) self-sampling test that can detect the methylation status of exfoliated cell genes in the intestine, help screen for colorectal cancer and precancerous lesions risk, and detect bowel cancer risk even in the absence of active bleeding lesions, according to BkkGI. Colorectal cancer is the third most common cancer … Continued

CHUV, CERN and THERYQ join forces for a world first in cancer radiotherapy

By asianet

The Centre Hospitalier Universitaire Vaudois (CHUV) in Lausanne, Switzerland, the European Laboratory for Particle Physics (CERN) and THERYQ (ALCEN Group) have signed an agreement for the world-first development of a revolutionary FLASH radiotherapy device that will use very high energy electron (VHEE) radiation to treat cancers resistant to conventional treatments. The device, based on CERN … Continued

The 13th China (Taizhou) International Medical Expo successfully held

By asianet

From November 19 to 21, the 13th China (Taizhou) International Medical Expo was held in China Medical City (CMS). Themed “Healthy China Strategy Leading the Construction of Demonstration Zones”, this year’s expo held 23 special events including the CMS Policy Releasing and Project Signing Ceremony, and the 9th China (Taizhou) International Big Health Industry Talent … Continued